Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Penack

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Haematologica|December 11, 2008
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and OncologyOliver A Cornely, Angelika Böhme, Dieter Buchheidt, et al.
Bone Marrow Transplantation|August 23, 2023
Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMTLars Klingen Gjærde, Christophe Peczynski, Emmanuelle Polge, et al.
Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Annals of Hematology|May 29, 2012
Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Florian Weissinger, Holger W Auner, Hartmut Bertz, et al.
Bone Marrow Transplantation|June 11, 2022
Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation networkVladimir Perovic, Ivan Sabol, Magdalena Grce, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2026
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in GermanyMarie Engelhard, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Annals of Hematology|October 15, 2008
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Angelika Böhme, Markus Ruhnke, et al.
Bone Marrow Transplantation|September 25, 2021
Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMTZinaida Peric, Christophe Peczynski, Emmanuelle Polge, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2020
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registrySebastian Birndt, Thomas Schenk, Babett Heinevetter, et al.
Leukemia|April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working partyOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Haematologica|December 11, 2008
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and OncologyOliver A Cornely, Angelika Böhme, Dieter Buchheidt, et al.
Bone Marrow Transplantation|August 23, 2023
Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMTLars Klingen Gjærde, Christophe Peczynski, Emmanuelle Polge, et al.
Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Annals of Hematology|May 29, 2012
Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Florian Weissinger, Holger W Auner, Hartmut Bertz, et al.
Bone Marrow Transplantation|June 11, 2022
Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation networkVladimir Perovic, Ivan Sabol, Magdalena Grce, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2026
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in GermanyMarie Engelhard, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Annals of Hematology|October 15, 2008
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Angelika Böhme, Markus Ruhnke, et al.
Bone Marrow Transplantation|September 25, 2021
Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMTZinaida Peric, Christophe Peczynski, Emmanuelle Polge, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2020
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registrySebastian Birndt, Thomas Schenk, Babett Heinevetter, et al.
Leukemia|April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working partyOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Pageof 19